ArticleNPJ Parkinson's disease2019
State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease.
Article in NPJ Parkinson's disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Case Definitions and Data Sources for NNCSS Parkinson Disease Surveillance: A Systematic Review.JAMA network open · 2026Pooled it
- Pooled it
- Association Between Parkinson's Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis.Journal of Parkinson's disease · 2022Pooled it
- Primary prevention of Parkinson's disease: proceedings, the 8C's and a position statement from the Parkinson's disease prevention think tank.NPJ Parkinson's disease · 2026Review
- The Ecology of Care in Parkinson's Disease.Movement disorders clinical practice · 2026Article
- Machine learning prediction of discharge destination in patients with Parkinson's disease; a nationwide cohort study.NPJ Parkinson's disease · 2026Article
- Machine Learning Prediction of Discharge Destination in Patients with Parkinson's Disease; A Nationwide Cohort Study.Research square · 2026Article
- Proceedings of the world summit on parkinson's disease.NPJ Parkinson's disease · 2025Article
- Real-World Analysis of Healthcare Utilization, Treatment Patterns, and Economic Burden in Medicare Beneficiaries with Parkinson's Disease: Implications by Levodopa Formulation and Disease Severity.PharmacoEconomics - open · 2025Article
- Centering the person in development of a model of care for people with Parkinson's disease: a qualitative study.Disability and rehabilitation · 2025Article
- Economic evaluation of mHealth solutions in PD: where do we stand?Neurodegenerative disease management · 2025Article
- Regional changes in the prevalence of Parkinson's disease over a ten-year period in the state of Texas.Clinical parkinsonism & related disorders · 2025Article
- Associations of street-view greenspace with Parkinson's disease hospitalizations in an open cohort of elderly US Medicare beneficiaries.Environment international · 2024Article
- Animal Approaches to Studying Risk Factors for Parkinson's Disease: A Narrative Review.Brain sciences · 2024Review
- Adjusting for Underrepresentation Reveals Widespread Underestimation of Parkinson's Disease Symptom Burden.Movement disorders : official journal of the Movement Disorder Society · 2023Article
- Sociodemographic and Geographic Disparities in End-of-Life Health Care Intensity Among Medicare Beneficiaries With Parkinson Disease.Neurology. Clinical practice · 2023Article
- Shingles vaccination reduces the risk of Parkinson's disease.Chronic diseases and translational medicine · 2023Article
- Parkinson's disease population-wide registries in the United States: Current and future opportunities.Frontiers in digital health · 2023Article
- Standardizing default electronic health record tools to improve safety for hospitalized patients with Parkinson's disease.Frontiers in aging neuroscience · 2023Article
- Associations of Greenness, Parks, and Blue Space With Neurodegenerative Disease Hospitalizations Among Older US Adults.JAMA network open · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
State-level variations in disease, healthcare utilization, and spending influence healthcare planning at federal and state levels and should be examined to understand national disparities in health outcomes. This descriptive study examined state-level variations in Parkinson disease (PD) prevalence, patient characteristics, Medicare spending, out-of-pocket costs, and health service utilization using data on 27.5 million Medicare beneficiaries in the US in 2014. We found that 45.8% (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.